来源：新浪证券-红岸工作室 1月8日，超研股份涨5.15%，成交额1.66亿元，换手率12.02%，总市值101.51亿元。 异动分析 宠物经济+医疗器械概念+水利+人民币贬值受益+注册制次新股 1、2025年3月8日官微：SIUI于3月3日至5日参加了第97届WVC年会。在此次盛会上，SIUI展出了我们 在宠物、马匹和家畜方面的创新兽用医学影像成果，与行业专家就动物医疗保健的发展进行了交流，并 在与一线从业者的交流中获得了宝贵的用户见解。 2、汕头市超声仪器研究所股份有限公司的主营业务是从事医学影像设备、工业无损检测设备的研发、 生产和销售；公司主要产品包括掌上式无线彩超、便携式彩超、推车式彩超、全容积乳腺超声成像系 统、全数字超声显像诊断仪、便携式X射线机、便携式数字化X射线摄影系统、数字超声探伤仪、超声 成像检测仪、自动检测装置和探头、医用超声探头、工业无损检测探头； 5、汕头市超声仪器研究所股份有限公司于2025-01-22日上市，主营业务为医学影像设备、工业无损检 测设备的研发、生产和销售。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入1 ...

1月8日，迪安诊断盘中上涨2.04%，截至09:54，报17.49元/股，成交9771.20万元，换手率1.13%，总市 值109.31亿元。 资金流向方面，主力资金净流出130.59万元，特大单买入104.21万元，占比1.07%，卖出463.49万元，占 比4.74%；大单买入2044.16万元，占比20.92%，卖出1815.46万元，占比18.58%。 分红方面，迪安诊断A股上市后累计派现10.99亿元。近三年，累计派现7.12亿元。 机构持仓方面，截止2025年9月30日，迪安诊断十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1056.35万股，相比上期减少423.50万股。南方中证1000ETF（512100）位居第七大流通股 东，持股456.88万股，相比上期减少4.09万股。医疗器械ETF（159883）位居第十大流通股东，持股 308.75万股，为新进股东。招商优势企业混合A（217021）、长城消费增值混合A（200006）退出十大 流通股东之列。 责任编辑：小浪快报 资料显示，迪安诊断技术集团股份有限公司位于浙江省杭州市西湖区金蓬街329号2幢5层，成立日期 2001年9 ...

Group 1 - The core viewpoint of the article is that the company, 港通医疗, is focused on providing medical gas equipment and systems, as well as clean medical equipment and systems, which are integral to the construction of smart hospitals [1] - The company is actively monitoring the development of AI in healthcare and is committed to enhancing the intelligence level of its products to meet the growing demands of modern hospital construction [1] - 港通医疗's response indicates a dedication to addressing medical gas supply and infection control issues within healthcare institutions [1]

Core Viewpoint - During the "14th Five-Year Plan" period, Wuhai City has focused on a people-centered approach, systematically building a multi-level social security system to improve public services, living conditions, and social governance, resulting in significant improvements in people's livelihoods [5][12]. Public Safety and Social Governance - Wuhai City has achieved a notable decline in crime rates, with criminal cases down by 26.2%, property crimes by 39.1%, and traditional theft and fraud cases by 53.7% [5]. - The city has established standardized community governance centers in all three districts and 20 towns, effectively resolving conflicts and disputes [5]. Education and Health - A total of 101.97 billion yuan has been invested in education, with 181 projects implemented, significantly improving school conditions [5]. - The coverage rate of inclusive kindergartens remains above 97%, with 62.9% of children attending public kindergartens, an increase of nearly 10 percentage points compared to the previous five-year plan [6]. - Wuhai City has built a tight-knit medical group system, with over 2,600 expert visits and 47,000 patient transfers, while also reducing medical costs for residents by 140 million yuan since 2021 [7][11]. Employment and Social Security - The city has created 27,100 new urban jobs over five years, exceeding targets, and has provided job placement for 2,161 individuals through public service positions [8]. - The minimum living guarantee standard has increased by 21.45% since 2020, benefiting over 441,600 people with a total of 380 million yuan distributed [8]. Elderly Care and Community Services - Wuhai City has established a comprehensive elderly care service network, achieving 100% coverage of urban and rural elderly facilities ahead of schedule [9]. - A total of 94 elderly service centers have been built, enhancing the quality of life for the elderly population [9]. Urban Development and Transportation - The city's road network has expanded to 1,151 kilometers, with a density of 65.6 kilometers per 100 square kilometers, significantly above the regional average [10]. - Wuhai Airport has seen a 17.5% increase in passenger throughput, surpassing 800,000 for the first time, with 23 cities now connected by air [10]. Healthcare and Insurance Reforms - The number of people covered by basic medical insurance has increased from 384,600 to 421,500, with a coverage rate of over 95% [11]. - The reimbursement rates for inpatient care under employee and resident insurance have exceeded expectations, benefiting over 322,300 individuals and reducing costs by 11.573 million yuan [11].

新京报讯（记者戴轩）西城区两会于近日开幕，记者从会上获悉，去年西城区人均期望寿命达到85.05 岁，孕产妇死亡率0/10万。 在医疗服务体系方面，该区在北京市率先建成覆盖11家区属医院的一体化信息系统，全面打通数据壁 垒，累计落地20余项智慧医疗应用场景，居民非诊疗就医时间平均缩短30-40分钟。 2026年，该区将开展"卫生健康数智赋能行动"，依托一体化平台，构建健康大数据与人工智能底座，围 绕"居民少跑腿、监管更智能"目标，推动更多"AI +医疗"健康应用场景落地。 西城区委卫健工委书记、区卫健委主任焦扬介绍，2025年，西城区人均期望寿命达到85.05岁，孕产妇 死亡率0/10万，婴儿死亡率1.38‰，法定传染病发病率较2024年同期下降27.5%，在全国率先落实育儿 补贴政策，惠及0-3岁婴幼儿3万余名。 ...

本报讯（记者 陈强 孙乐琪）昨天上午，首都医科大学宣武医院房山院区暨国家医学中心建设工程建设 动员会在房山区长阳镇举行，标志着该项目正式启动建设。作为本市重点推进的公共服务工程，项目预 计2029年投用，建成后将成为房山区首家三级甲等综合医院，有效提升京西南优质医疗服务能力。 宣武医院现址位于西城区，此次启动的房山院区东片区占地14.3万平方米，总建筑面积19.89万平方米， 规划床位800张。 宣武医院房山院区将打造集智慧、韧性、绿色于一体的"智慧健康生态综合体"。建筑设计独具匠心，南 北两组主体建筑通过放射状交通体系连接中央大厅，形成高效诊疗动线，实现临床、教学、科研、康复 等功能区无缝衔接。这一设计形似神经元共生形态，既凸显了宣武医院在神经科学领域的特色优势，也 为多学科协同发展提供支撑。 智慧医疗是新院区一大亮点。宣武医院房山院区将搭建与宣武医院西城院区同源的数字化诊疗平台，全 面落地远程会诊、人工智能辅助诊断等技术，并引入核磁共振等尖端医疗设备。同时深度融合"互联网 +医疗"模式，患者通过"掌上宣武医院"平台，即可完成在线复诊、医保实时结算、药品配送到家等全流 程服务。 该院区距离地铁房山线广阳城站 ...

房山院区在设计上创新采用"神经元共生"建筑理念，南北两组主体建筑通过放射状交通体系相连，围绕 中央大厅形成高效诊疗动线，实现临床、教学、科研、康复等功能区的无缝衔接。这一设计理念旨在为 多学科协同发展提质增效。 项目深度融合"互联网+医疗"服务模式，患者可通过"掌上宣武医院"平台，完成在线复诊、医保实时结 算、药品配送到家等全流程服务。 同时，新院区将搭建与西城院区同源的数字化诊疗平台，实现远程会诊、人工智能辅助诊断等智慧医疗 技术的场景应用。 （来源：千龙网） 1月6日上午，首都医科大学宣武医院房山院区暨国家医学中心建设工程建设动员会在北京市房山区长阳 镇举行，标志着该项目正式进入建设实施阶段。 首都医科大学宣武医院现址位于西城区，本次启动建设的是该院房山院区东片区，位于房山区长阳镇， 占地面积14.3万平方米，总建筑面积19.89万平方米，规划床位800张，预计于2029年建成投入使用。 项目建成后，将弥补北京西南部地区优质医疗资源短板，助力北京市区域综合医疗水平提升。 房山院区邻近地铁房山线广阳城站，将通过轨道交通一体化设计，压缩患者"出家门到进诊室"的时间， 方便老年及行动不便的患者就医。 新京报记者 ...

Group 1 - The core viewpoint of the news is that the stock price of Chongqing Shanwaishan Blood Purification Technology Co., Ltd. has shown fluctuations, with a recent decline of 2.01% and a current trading price of 15.61 yuan per share, while the company has experienced a year-to-date stock price increase of 4.28% [1][2] - As of October 31, 2025, the company reported a revenue of 584 million yuan, representing a year-on-year growth of 39.79%, and a net profit attributable to shareholders of 104 million yuan, reflecting a year-on-year increase of 68.68% [2] - The company specializes in the research, production, and sales of blood purification equipment, with its main business revenue composition being 66.12% from blood purification equipment, 23.89% from blood purification consumables, 8.31% from medical services, and 1.68% from other sources [2] Group 2 - The company has distributed a total of 104 million yuan in dividends since its A-share listing [3] - As of September 30, 2025, the top ten circulating shareholders include new shareholder Penghua Medical Technology Stock A, holding 5.182 million shares, and BoShi Medical Care Mixed A, holding 3.257 million shares, with the latter's shareholding remaining unchanged from the previous period [3]

Core Viewpoint - The company, Fule New Materials (福莱新材), has highlighted the versatility of its flexible sensor technology, which can be applied in various fields such as humanoid robots, industrial inspection, wearable devices, and smart healthcare [1]. Company Summary - Fule New Materials (605488) has engaged with investors on an interactive platform, emphasizing the potential applications of its flexible sensor technology [1].

Core Viewpoint - The company Fule New Materials (福莱新材) has announced that its flexible sensor technology can be applied in various fields including humanoid robots, industrial inspection, wearable devices, and smart healthcare [1] Company Summary - Fule New Materials (605488) is actively engaging in the development of flexible sensor technology [1] - The company is exploring applications of its technology in multiple sectors, indicating a broad market potential [1] Industry Summary - The flexible sensor technology is positioned to impact several emerging industries such as robotics, industrial automation, wearable technology, and healthcare [1] - The integration of flexible sensors in these fields suggests a trend towards increased automation and smart technology solutions [1]